Region: Brazil

Phase III of the PPH programme comes into effect

Brazil has consolidated its effective Patent Prosecution Highway strategy by extending the number of applications that can be submitted to the National Institute of Industrial Property.

19 January 2022

Brazil starts 2022 with a fresh national IP strategy

The long-awaited 10-year strategy, which is designed to improve the IP system in Brazil with the civil and governmental support, has finally come into force.

12 January 2022

The biggest biopharma patent stories of the year

From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries

21 December 2021

Phase II of Brazilian PPH hits its limit

Brazil has enjoyed consistent success with PPH programmes, as evidenced by Phase II of the programme starting and finishing considerably earlier than anticipated.

24 November 2021

INPI decision clarifies when a preferential right to registration can be claimed

There has been confusion with regard to when an applicant can claim the preferential right to registration of a trademark. However, a fresh case provides some much-needed clarity.

17 November 2021

National IP Strategy aims to make Brazil a world-class hub for innovation

Brazil is seeking to improve its IP system by creating a National IP Strategy designed to stimulate innovation. This strategy aims to position Brazil among the 10 countries with the highest number of IP protection requests within the next decade.

27 October 2021

Position trademarks are now available for registration in Brazil

The Brazil National Institute for Industrial Property is now processing position marks. While some of the details still need to be ironed out, permitting such marks for registration signals a great step forward for brand protection in the country.

06 October 2021

INPI introduces new proceedings now that ANVISA´s prior approval for pharma patents is over

Brazil’s recent overhaul of its procedures for handling patents is well underway. So far it is yielding positive results, especially with regard to pharmaceutical and biotechnology patents.

22 September 2021

Pharmaceutical patent applications are no longer subject to ANVISA’s prior approval

As the Brazilian Ministry of Economy looks to boost the country’s market by introducing new legal measures, pharmaceutical patent holders and future applicants will no longer be required to go through two regulatory bodies. This should make obtaining patent approval in Brazil a much smoother process.

08 September 2021

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law

The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force

03 September 2021

Get unlimited access to all IAM content